• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201601009547822170 Update date: Jun. 07, 2023

TEPPEI YAMADA

ヤマダ テッペイ | TEPPEI YAMADA
Clips

MISC (9)

  • Tomohiro Kurokawa, Teppei Yamada, Lei Cai, Soldano Ferrone, Cristina R. Ferrone. B7-H3-Specific Chimeric-Antigen Receptor T-Cell-Based Immunotherapy for Intrahepatic Cholangiocarcinoma. Journal of the American College of Surgeons. 2018. 227. 4. S236
  • Naoya Aisu, Yoichiro Yoshida, Akira Komono, Teppei Yamada, Daibo Kojima, Toshiyuki Mera, Syu Tanimura, Yuichi Yamashita. Perioperative chemotherapy with S-1 plus oxaliplatin (SOX) for stage III colorectal cancer patients. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 4
  • Taisuke Matsuoka, Yoichiro Yoshida, Ai Mogi, Teppei Yamada, Naoya Aisu, Daibo Kojima, Syu Tanimura, Tomoko Koganemaru, Fumiaki Kiyomi, Yuichi Yamashita. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy. ANNALS OF ONCOLOGY. 2015. 26. 114-114
  • Yoichiro Yoshida, Kenichiro Ogura, Akira Hiratsuka, Naoya Aisu, Yamada Teppei, Kojima Daibo, Syu Tanimura, Kentaro Ogata, Syuji Hara, Yuichi Yamashita. Potential of the 5-fluorouracil dose-escalation method for dihydropyrimidine dehydrogenase-deficient patients. ANNALS OF ONCOLOGY. 2015. 26. 140-140
  • Naoya Aisu, Yoichiro Yoshida, Teppei Yamada, Taisuke Matsuoka, Daibo Kojima, Syu Tanimura, Seiichiro Hoshino, Ai Mogi, Tomoko Koganemaru, Mayumi Oda, et al. The difference between the subjective and objective evaluation of oxaliplatin-induced vascular pain due to administer chemotherapy via peripheral vein. JOURNAL OF CLINICAL ONCOLOGY. 2015. 33. 3
  • 菅原 俊一, 山田 哲平, 松枝 智子, 吉山 康一, 坂本 信二郎, 石本 修, 小松 誠和, 山田 亮, 高森 信三, 笹田 哲朗, et al. 非小細胞肺癌に対する3・4次治療としての個別化ペプチドワクチン療法のfeasibility study. 肺癌. 2014. 54. 5. 562-562
  • 坂本 信二郎, 山田 哲平, 寺崎 泰宏, 吉山 康一, 松枝 智子, 小松 誠和, 和氣 加容子, 山田 亮, 菅原 俊一, 笹田 哲朗, et al. 既二次治療進行非小細胞癌に対するテーラーメイドペプチドワクチン療法の臨床第II相試験(The phase II clinical study of personalized peptide vaccination for NSCLC patients who failed two or more regimens). 日本癌学会総会記事. 2014. 73回. P-1225
  • 坂本 信二郎, 山田 哲平, 寺崎 泰宏, 吉山 康一, 松枝 智子, 小松 誠和, 和氣 加容子, 山田 亮, 河原 明彦, 鹿毛 政義, et al. 既二次治療進行非小細胞癌に対するテーラーメイドペプチドワクチン療法の臨床第II相試験. 日本がん免疫学会総会プログラム・抄録集. 2014. 18回. 72-72
  • 山田 哲平, 東 公一, 菅原 俊一, 松枝 智子, 山下 裕一, 伊東 恭悟, 笹田 哲朗. EGFR-TKI耐性の非小細胞肺がん患者に対する新規免疫療法の標的としてEGFR T790M変異由来のT細胞抗原の同定(EGFR T790M-derived T Cell Epitopes as a Target for Immunotherapy against EGFR-TKI-resistant Non-Small Cell Lung Cancer). 日本癌学会総会記事. 2013. 72回. 367-367

1 to 9 of 9 results
  • « Top
  • ‹ Prev
  • 1
  • Next ›
  • Last »
Return to Previous Page